ArticleFrontline gastroenterology2022

Influence of comorbidities on treatment considerations for first-line biologic prescribing in patients with inflammatory bowel disease in the UK.

Ayesha Akbar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.